As a Global Commercialization Executive, I am known for conceiving, planning, and launching disruptive medical technologies across global markets from inception to scale, consistently exceeding corporate objectives and financial goals.A trusted advisor and an independent board director for companies looking to grow their international business, I successfully shepherd organizations, from small early-clinical-stage private ventures to global commercial enterprises across a spectrum of technologies.My teams thrive within the culture of shared vision, battlefield experience, and accountability I promote. Additionally, I work proactively with the management to realign organizational structures based on the ever-changing landscape of opportunities and occasionally adverse market conditions.How do I advise my teams to succeed?STRATEGIC EXECUTION: My value is identifying expansion opportunities to increase enterprise value, helping management design strategic road maps grounded in understanding market dynamics, regulatory environments, and customer insights, and setting realistic but challenging execution plans. GLOBAL COMMERCIAL LEADERSHIP: I have been exceptionally resourceful in leveraging my extensive network across the med-tech industry to recruit exceptional talent globally. Additionally, I assist management in actively engaging with strategic partners, critical societies, prominent physicians, advisors, and advocacy groups to enhance organizational visibility, helping to ensure commercial success.FINANCIAL & RISK MANAGEMENT: Working with the company leadership, my collaborative style focuses on managing potential exposures. Additionally, I instill a culture of integrity in my team by providing the necessary tools and training. ORGANIZATIONAL DEVELOPMENT: I foster a culture of shared vision, leveraging industry experience and personal/team accountability, coupled with an innate ability to identify, develop, and mentor diverse and inclusive executive talent. Currently, I am looking to add one more board director position, preferably with a late-stage private company.